These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 27467504)
1. Risk prediction in Barrett's esophagus - aspects of a combination of molecular and epidemiologic biomarkers reflecting alterations of the microenvironment. Brandtner AK; Quante M Scand J Clin Lab Invest Suppl; 2016; 245():S63-9. PubMed ID: 27467504 [TBL] [Abstract][Full Text] [Related]
3. Molecular markers and genetics in cancer development. Hormi-Carver K; Souza RF Surg Oncol Clin N Am; 2009 Jul; 18(3):453-67. PubMed ID: 19500736 [TBL] [Abstract][Full Text] [Related]
4. Management of Barrett's esophagus: cases and questions. Bresalier R Semin Oncol; 2005 Dec; 32(6 Suppl 9):S2-5. PubMed ID: 16399421 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma. Runge TM; Abrams JA; Shaheen NJ Gastroenterol Clin North Am; 2015 Jun; 44(2):203-31. PubMed ID: 26021191 [TBL] [Abstract][Full Text] [Related]
6. Risk factors, DNA damage, and disease progression in Barrett's esophagus. Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340 [TBL] [Abstract][Full Text] [Related]
7. Understanding cancer incidence in Barrett's esophagus: light at the end of the tunnel. Corley DA J Natl Cancer Inst; 2011 Jul; 103(13):994-5. PubMed ID: 21680911 [No Abstract] [Full Text] [Related]
8. Etiology of Barrett's metaplasia and esophageal adenocarcinoma. Kim R; Weissfeld JL; Reynolds JC; Kuller LH Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):369-77. PubMed ID: 9149898 [TBL] [Abstract][Full Text] [Related]
9. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus. Whitson MJ; Falk GW Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for esophageal cancer development. Falk GW Surg Oncol Clin N Am; 2009 Jul; 18(3):469-85. PubMed ID: 19500737 [TBL] [Abstract][Full Text] [Related]
11. Epidemiologic Risk Factors in a Comparison of a Barrett Esophagus Registry (BarrettNET) and a Case-Control Population in Germany. Schmidt M; Ankerst DP; Chen Y; Wiethaler M; Slotta-Huspenina J; Becker KF; Horstmann J; Kohlmayer F; Lehmann A; Linkohr B; Strauch K; Schmid RM; Quante AS; Quante M Cancer Prev Res (Phila); 2020 Apr; 13(4):377-384. PubMed ID: 32066580 [TBL] [Abstract][Full Text] [Related]
12. Risk factors in the development of esophageal adenocarcinoma. Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis and recognition of early esophageal neoplasia. Herszényi L; Pregun I; Tulassay Z Dig Dis; 2009; 27(1):24-30. PubMed ID: 19439957 [TBL] [Abstract][Full Text] [Related]
14. Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants. Dong J; Buas MF; Gharahkhani P; Kendall BJ; Onstad L; Zhao S; Anderson LA; Wu AH; Ye W; Bird NC; Bernstein L; Chow WH; Gammon MD; Liu G; Caldas C; Pharoah PD; Risch HA; Iyer PG; Reid BJ; Hardie LJ; Lagergren J; Shaheen NJ; Corley DA; Fitzgerald RC; ; Whiteman DC; Vaughan TL; Thrift AP Gastroenterology; 2018 Apr; 154(5):1273-1281.e3. PubMed ID: 29247777 [TBL] [Abstract][Full Text] [Related]
15. [Diagnosis of gastroesophageal reflux and Barrett esophagus]. von Schrenck T Zentralbl Chir; 2000; 125(5):414-23. PubMed ID: 10929625 [TBL] [Abstract][Full Text] [Related]
16. The diagnosis and management of Barrett's esophagus. DeMeester SR; DeMeester TR Adv Surg; 1999; 33():29-68. PubMed ID: 10572561 [TBL] [Abstract][Full Text] [Related]